Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: Results from a multicenter study in India

International Journal of Cancer

Volumn 116, Issue 5, 2005, Pages 830-831

  Khan, Michelle J ^a,b,c   Schiffman, Mark ^a   Jeronimo, Jose ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c EPS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; LUGOL; VIRUS DNA;

ADULT; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; DIAGNOSTIC ACCURACY; HUMAN; INDIA; LETTER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 23244442405     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21084     Document Type: Letter

References (5)

1. Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, Mahe C, Muwonge R, Seigneurin D, Somanathan T, Roy C, Kelkar R, Chinoy R, et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer 2004;112:341-7.
2. Ferreccio C, Bratti MC, Sherman ME, Herrero R, Wacholder S, Hildesheim A, Burk RD, Hutchinson M, Alfaro M, Greenberg MD, Morales J, Rodriguez AC, et al. A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer. Cancer Epidemiol Biomarkers Prev 2003;12:815-23.
3. Cuzick J, Szarewski A, Cubic H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R, Brooks C, Desai M, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003;362: 18716.
4. Schiffman M, Khan MJ, Solomon D, Herrero R, Wacholder S, Hildesheim A, Rodriguez AC, Bratti MC, Wheeler CM, Burk RD, for the-PEG Group and the ALTS Group. A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst 2005;97:147-0.
5. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-92.